99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor

Nuclear Medicine and Biology

Volumn 35, Issue 3, 2008, Pages 263-272

  Lane, Stephanie R ^b,c   Veerendra, Bhadrasetty ^a   Rold, Tammy L ^a   Sieckman, Gary L ^b   Hoffman, Timothy J ^a,b,c   Jurisson, Silvia S ^c   Smith, Charles J ^a,b,c  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Biodistribution; Bombesin; Internalization; Prostate; Tricarbonyl; Tridentate

Indexed keywords

2 (N,N' BIS(TERT BUTOXYCARBONYL)DIETHYLENETRIAMINE) ACETIC ACID; BOMBESIN; GASTRIN RELEASING PEPTIDE RECEPTOR; TRACER; TRICARBONYL 2 (N,N' BIS(TERT BUTOXYCARBONYL)DIETHYLENETRIAMINE) ACETIC ACID BETA ALANYLGLUTAMINYLTRYPTOPHYLALANYLVALYLGLYCYLHISTIDYLLEUCYLMETHIONYLAMIDE TC 99M; TRICARBONYL 2 (N,N' BIS(TERT BUTOXYCARBONYL)DIETHYLENETRIAMINE) ACETIC ACID GLYCYLGLYCYLGLYCYLGLUTAMINYLTRYPTOPHYLALANYLVALYLGLYCYLHISTIDYLLEUCYLMETHIONYLAMIDE TC 99M; TRICARBONYL 2 (N,N' BIS(TERT BUTOXYCARBONYL)DIETHYLENETRIAMINE) ACETIC ACID GLYCYLSERYLGLYCYLGLUTAMINYLTRYPTOPHYLALANYLVALYLGLYCYLHISTIDYLLEUCYLMETHIONYLAMIDE TC 99M; TRICARBONYL 2 (N,N' BIS(TERT BUTOXYCARBONYL)DIETHYLENETRIAMINE) ACETIC ACID SERYLSERYLSERYLGLUTAMINYLTRYPTOPHYLALANYLVALYLGLYCYLHISTIDYLLEUCYLMETHIONYLAMIDE TC 99M; UNCLASSIFIED DRUG; ACETIC ACID; ACETIC ACID DERIVATIVE; BOMBESIN RECEPTOR; CARRIER PROTEIN; CHELATING AGENT; DIETHYLENETRIAMINE; DRUG DERIVATIVE; MONOVALENT CATION; POLYAMINE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG UPTAKE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; ISOTOPE LABELING; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE SYNTHESIS; PROSTATE CANCER; PROTEIN STRUCTURE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; BINDING COMPETITION; CANCER TRANSPLANTATION; CHEMISTRY; DISEASE MODEL; FEMALE; MALE; METABOLISM; METHODOLOGY; MOUSE MUTANT; PROSTATE TUMOR; PROTEIN BINDING; SCINTISCANNING; SYNTHESIS; TUMOR CELL LINE;

ACETIC ACID; ACETIC ACIDS; ANIMALS; BINDING, COMPETITIVE; BOMBESIN; CARRIER PROTEINS; CATIONS, MONOVALENT; CELL LINE, TUMOR; CHELATING AGENTS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; ISOTOPE LABELING; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; ORGANOTECHNETIUM COMPOUNDS; POLYAMINES; PROSTATIC NEOPLASMS; PROTEIN BINDING; RADIOPHARMACEUTICALS; RECEPTORS, BOMBESIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TECHNETIUM;

EID: 41049098304     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.11.007     Document Type: Article

References (42)

1. West S.D., and Mercer D.W. Bombesin-induced gastroprotection. Ann Surg 241 (2005) 227-231
2. Fleischmann A., Läderach U., Friess H., Buechler M.W., and Reubi J.C. Bombesin receptors in distinct tissue compartments of human pancreatic diseases. Lab Invest 80 (2000) 1807-1817
3. 2] Conjugate: a novel targeting vector for positron emission tomographic imaging of gastrin releasing peptide receptor-expressing tissues. Proc Natl Acad Sci U S A 104 (2007) 12462-12467
4. 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems. J Nucl Med 48 (2007) 1327-1337
5. 111In-labelled bombesin analogues for molecular imaging of prostate tumors. Eur J Nucl Med Mol Imaging 34 (2007) 1228-1238
6. 4)-bombesin(1-14). Bioconjug Chem 18 (2007) 724-730
7. Parry J.J., Andrews R., and Rogers B.E. MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor. Breast Cancer Res Treat 101 (2007) 175-183
8. 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer. J Nucl Med 47 (2006) 1144-1152
9. 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. J Nucl Med 47 (2006) 492-501
10. Montet X., Yuan H., Weissleder R., and Josephson L. Enzyme-based visualization of receptor-ligand binding in tissues. Lab Invest 86 (2006) 517-525
11. 3 bombesin analogues. Nucl Med Biol 34 (2007) 17-28
12. 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties. Bioconjug Chem 18 (2007) 1110-1117
13. 2 (X=serylserylserine, glycylglycylglycine, glycylserylglycine, or beta-alanine). Synth React Inorg Met-Org Nano-Met Chem 36 (2006) 481-491
14. Marti N., Spingler B., and Schibli R. Comparative studies of substitution reactions of rhenium(I) dicarbonyl-nitrosyl and tricarbonyl complexes in aqueous media. Inorg Chem 44 (2005) 6082-6091
15. Méndez-Rojas M.A., Kharisov B.I., and Tsivadze A.Y. Recent advances on technetium complexes: coordination chemistry and medical applications. J Coord Chem 59 (2006) 1-63
16. Banerjee S.R., Babich J.W., and Zubieta J. A new bifunctional amino acid chelator targeting the glucose transporter. Inorganica Chim Acta 359 (2006) 1603-1612
17. Schibli R., and Schubiger P.A. Current use and future potential of organometallic radiopharmaceuticals. Eur J Nucl Med 29 (2002) 1529-1542
18. Abram U., and Alberto R. Technetium and rhenium-coordination chemistry and nuclear medical applications. J Braz Chem Soc 17 (2006) 1486-1500
19. Maria L., Cunha S., Videira M., Gano L., Paulo A., and Santos I.C. Rhenium and technetium tricarbonyl complexes anchored by pyrazole-based tripods: novel lead structures for the design of myocardial imaging agents. Dalton Trans 28 (2007) 3010-3019
20. 2Me}]Br. Inorg Chem Commun 7 (2004) 481-484
21. + cores. Inorganica Chim Acta 358 (2005) 3691-3700
22. Pearson R.G. Hard and soft acids and bases. J Am Chem Soc 85 (1963) 3533-3539
23. Pearson R.G. Hard and soft acids and bases, part I, fundamental principles. J Chem Ed 45 (1968) 581-587
24. Pearson R.G. Hard and soft acids and bases, part II, underlying theories. J Chem Ed 45 (1968) 643-648
25. Prasanphanich A.F., Lane S.R., Figueroa S.D., Ma L., Rold T.L., Sieckman G.L., et al. The effects of linking substituents on the in vivo behavior of site-directed, peptide-based. In vivo 21 (2007) 1-16
26. Rogers B.E., Bigott H.M., McCarthy D.W., Manna D.D., Joonyoung K., Sharp T.L., et al. MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. Bioconjugate Chem 14 4 (2003) 756-763
27. van der Lely A.J., de Herder W.W., Krenning E.P., and Kwekkeboom D.J. Octreoscan radioreceptor imaging. Endocrine 20 (2003) 307-311
28. Garcia-Garayoa E., Maes V., Blaeuenstein P., Blanc A., Hohn A., Tourwe D., et al. Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors. Nucl Med Bio 33 (2006) 495-503
29. Okarvi S.M. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases. Med Res Rev 24 (2004) 357-397
30. Smith C.J., Volkert W.A., and Hoffman T.J. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes. Nucl Med Bio 32 (2005) 733-740
31. Bandoli G., Tisato F., Dolmella A., and Agostini S. Structural overview of technetium compounds (2000-2004). Coord Chem Rev 250 (2006) 561-573
32. Jurisson S.S., and Lydon J.D. Potential technetium small molecule radiopharmaceuticals. Chem Rev 99 (1999) 2205-2218
33. 2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies. Anticancer Res 23 (2003) 63-70
34. 3. Cancer Res 63 (2003) 4082-4088
35. Varga G., Reidelberger R.D., Liehr R.M., Bussjaeger L.J., Coy D.H., and Solomon T.E. Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats. Peptides 12 (1991) 493-497
36. Fanger B.O., Wade A.C., and Cardin A.D. Characterization of the murine pancreatic receptor for gastrin releasing peptide and bombesin. Regul Pept 32 (1991) 241-251
37. Huang S.C., Yu D.H., Wank S.A., Gardner J.D., and Jensen R.T. Characterization of the bombesin receptor on mouse pancreatic acini by chemical cross-linking. Peptides 11 (1990) 1143-1150
38. Kane M.A., Kelley K., Ross S.E., and Portanova L.B. Isolation of a gastrin releasing peptide receptor from normal rat pancreas. Peptides 12 (1991) 207-213
39. 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. Bioconjugate Chem 13 (2002) 599-604
40. + moiety. Nucl Med Biol 33 (2006) 625-634
41. 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors. Nucl Med and Biol 29 (2002) 553-560
42. Mundwiler S., Candreia L., Häfliger P., Ortner K., and Alberto R. Preparation of no-carrier-added technetium-99m complexes via metal-assisted cleavage from a solid phase. Bioconjugate Chem 15 (2004) 195-202